Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy
Clinical trial NCT06542757 · RECRUITING
Trial details
- NCT number
- NCT06542757
- Sponsor
- NYU Langone Health
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-09
- Primary completion
- 2027-12-01
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.